World Opioids Drug Market was valued at USD XX Billion in the year 2019. World Opioids Drug Market is further estimated to grow at a CAGR of XX% from 2020 to reach USD XX Billion by the year 2028. The North America region holds the highest market share in 2020 and the Asia Pacific is considered as the fastest growing market in the forecasted period. At a country level, US, China are projected to grow strongly in the coming years due to increasing density of population and funding through Research and Development.
The World Opioids Drug Report 2020-2028 covers market opportunities and challenges, key market regulations’ information, analysis of new products from the market players and key market trends, market share analysis for key players, supply chain and value chain analysis, product and technology trends, pricing analysis, emerging Shopper Types, technologies and major recent developments. This information has also been provided for the major country markets in these regions. Market shares, size and growth potential are assessed for these major country markets. Market opportunities, challenges, government regulations, market share analysis by major competitors, recent major market developments (product launches, M&A, partnerships, etc.) and other information have been covered for the major country markets listed in this section.
On the basis of Category, the market is divided as Buprenorphine, Fentanyl, Hydrocodone, Morphine, Oxycodone, Tramadol, and Other Products. In which Buprenorphine for the largest market share due to increasing demand in future market trends. Regional breakdown and deep analysis of each of the aforesaid segments is included for North America, Europe, Asia-Pacific, and ROW.
Market player analysis of major companies such as Pfizer Inc., Boehringer Ingelheim, Janssen Pharmaceuticals, Inc., Sanofi S.A., Allergan, Plc, GlaxoSmithKline, Teva Pharmaceutical Industries Ltd., Sun Pharmaceuticals, Mallinckrodt Pharmaceuticals, and Endo Pharmaceuticals Inc., and others.
| Particular | Scope |
|---|---|
| Region |
|
| Historic Year | 2015 tо 2019 |
| Estimated Year | 2020 |
| Forecast Year | 2021 tо 2029 |
1 Introduction (Page No. - 15)
1.1 The objectives of this study
1.2 Market Definition
1.2.1 Market Scope
1.3 Research Methodology
1.4 Stakeholders
1.5 Currency
1.6 Research Assumptions
1.7 Limitation
2 Executive Summary (Page No. - 25)
3. Market Outlook (Page No. - 29)
3.1 Introduction
3.2 DROC Matrix
3.3 Market Challenges
3.4 Market Share Analysis
3.5 Value chain Analysis
3.6 COVID-19 Impacts on Global Opioids Drug Industry
4 Industry Trends (Page No. - 42)
4.1 Introduction
4.2 PESTEL Analysis
4.3 Porter’s Five Forces Model
4.3.1 Threat of new entrance
4.3.2 Threat of substitute product
4.3.3 Bargaining power of buyer
4.3.4 Bargaining power of supplier
4.3.5 Intensity of competitive rivalry
5 Opioids Drug Market Category Analysis (Page No. - 51)
5.1 Introduction
5.2 Benchmark Market Revenue Analysis by Category, 2015-2019
5.3 Estimated and Projected Market Analysis by Category, 2020-2030
5.4 Y-o-Y Growth Trend Analysis
5.5 Buprenorphine
5.6 Fentanyl
5.7 Hydrocodone
5.8 Morphine
5.9 Oxycodone
5.10 Tramadol
5.11 Others
6 Opioids Drug Market Shopper Type Analysis (Page No. - 60)
6.1 Introduction
6.2 Benchmark Market Revenue Analysis by Shopper Type, 2015-2019
6.3 Estimated and Projected Market Analysis by Shopper Type, 2020-2030
6.4 Y-o-Y Growth Trend Analysis
6.5 Pain Management
6.5.1 Neuropathic Pain
6.5.2 Migraine
6.5.3 Back Pain
6.5.4 Osteoarthritis Pain
6.5.5 Cancer Pain
6.5.6 Others
6.6 Diarrhea Treatment
6.7 Cough Treatment
7 Opioids Drug Regional Analysis (Page No. – 67)
7.1 Introduction
7.2 North America
7.2.1 Benchmark Market Revenue Analysis by Country, 2015-2019
7.2.2 Estimated and Projected Market Analysis by Country, 2020-2030
7.2.3 U.S.
7.2.4 Canada
7.2.5 Mexico
7.3 Europe
7.3.1 Benchmark Market Revenue Analysis by Country, 2015-2019
7.3.2 Estimated and Projected Market Analysis by Country, 2020-2030
7.3.3 U.K.
7.3.4 Germany
7.3.5 France
7.3.6 Rest of Europe
7.4 Asia-Pacific (APAC)
7.4.1 Benchmark Market Revenue Analysis by Country, 2015-2019
7.4.2 Estimated and Projected Market Analysis by Country, 2020-2030
7.4.3 Japan
7.4.4 China
7.4.5 India
7.4.6 Rest of APAC
7.5 Rest of the World (RoW)
7.5.1 Benchmark Market Revenue Analysis by Country, 2015-2019
7.5.2 Estimated and Projected Market Analysis by Country, 2020-2030
7.5.3 Middle East
7.5.4 Africa
7.5.5 Latin America
8 Company Profiles (Page No. - 87)
(Overview, Products & Services, Strategies & Insights, recent Developments)*
8.1 Pfizer Inc.
8.2 Boehringer Ingelheim
8.3 Janssen Pharmaceuticals, Inc.
8.4 Sanofi S.A.
8.5 Allergan, Plc
8.6 GlaxoSmithKline
8.7 Teva Pharmaceutical Industries Ltd.
8.8 Sun Pharmaceuticals
8.9 Mallinckrodt Pharmaceuticals
8.10 Endo Pharmaceuticals Inc.
FIGURE 1 RESEARCH METHODOLOGY
FIGURE 2 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED MARKET, 2020-2030, (USD MILLION)
FIGURE 3 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED MARKET, 2020-2030, (USD MILLION)
FIGURE 4 MARKET OVERVIEW
FIGURE 5 OPIOIDS DRUG EVOLUTION
FIGURE 6 MARKET SEGMENTATION
FIGURE 7 MARKET SHARE ANALYSIS
FIGURE 8 VALUE CHAIN ANALYSIS
FIGURE 9 PORTER’S FIVE FORCES ANALYSIS
FIGURE 10 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 11 Y-O-Y GROWTH TREND ANALYSIS BY CATEGORY
FIGURE 12 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 13 Y-O-Y GROWTH TREND ANALYSIS BY SHOPPER TYPE
FIGURE 14 WORLD OPIOIDS DRUG VOLUME SHARE ESTIMATED AND PROJECTED REGIONAL ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 15 MARKET OVERVIEW REGIONAL ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 16 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 17 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 18 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 19 U.S. OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 20 U.S. OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 21 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 22 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 22 MEXICO OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 23 MEXICO OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 24 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 25 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 26 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 27 U.K. OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 28 U.K. OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 29 GERMANY OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 30 GERMANY OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 31 FRANCE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 32 FRANCE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 33 REST OF EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 34 REST OF EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 35 APAC OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 36 APAC OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 37 APAC OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 38 JAPAN OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 39 JAPAN OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 40 CHINA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 41 CHINA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 42 INDIA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 43 INDIA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 44 REST OF APAC OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 45 REST OF APAC OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 46 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 47 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 48 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 49 MIDDLE EAST OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 50 MIDDLE EAST OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 51 AFRICA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 52 AFRICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 53 LATIN AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030, (USD MILLION)
FIGURE 54 LATIN AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030, (USD MILLION)
TABLE 1 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED REGIONAL ANALYSIS, 2020-2030 (USD MILLION)
TABLE 2 WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY CATEGORY, 2015-2019, (USD MILLION)
TABLE 3 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 4 WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY SHOPPER TYPE, 2015-2019, (USD MILLION)
TABLE 5 WORLD OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 6 NORTH AMERICA WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 7 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 8 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 9 NORTH AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 10 U.S. OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 11 U.S. OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 12 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 13 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 14 MEXICO OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 15 CANADA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 16 EUROPE WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 17 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 18 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 19 EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 20 U.K. OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 21 U.K. OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 22 GERMANY OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 23 GERMANY OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 24 FRANCE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 25 FRANCE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 26 REST OF EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 27 REEST OF EUROPE OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 28 ASIA-PACIFIC WORLD OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 29 ASIA-PACIFIC OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 30 ASIA-PACIFIC OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 31 ASIA-PACIFIC OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 32 JAPAN OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 33 JAPAN OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 34 CHINA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 35 CHINA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 36 INDIA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 37 INDIA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 38 REST OF APAC OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 39 REST OF APAC OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 40 ROW OPIOIDS DRUG BENCHMARK MARKET REVENUE ANALYSIS BY COUNTRY, 2015-2019, (USD MILLION)
TABLE 41 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED COUNTRY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 42 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 43 ROW OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 44 MIDDLE EAST OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 45 MIDDLE EAST OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 46 AFRCA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 47 AFRICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
TABLE 48 LATIN AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED CATEGORY ANALYSIS, 2020-2030 (USD MILLION)
TABLE 49 LATIN AMERICA OPIOIDS DRUG ESTIMATED AND PROJECTED SHOPPER TYPE ANALYSIS, 2020-2030 (USD MILLION)
Global Starch Capsule Market By Type (1, 2, 3, 4, 5, Other size), By Application (Pharmaceutical, Nutraceutical), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Iloprost Drugs Market By Type (Inhaled, Intravenous), By Application (Hospital, Clinic), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Antibiotic API Market By Type (Penicillins, Cephalosporins, Aminoglycosides, Tetracyclines, Quinolones, Macrolides, Lincomycins), By Application (Oral Medicine, Injection Medicine), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Zoladex Market By Type (1M Zoladex, 3M Zoladex), By Application (Prostate Cancer, Breast Cancer, Endometriosis, Fibroids), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Aminoglycosides Antibiotics Market By Type (Neomycin, Tobramycin, Gentamicin, Amikacin, Etimicin), By Application (Hospital, Clinic, Post Care Facility, Government & Military), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global THF-OL Market By Type (R-3-THF-OL, S-3-THF-OL, Rac-3-THF-OL), By Application (Pesticide Intermediates, Pharmaceutical Intermediates), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Piperacillin Sodium (CAS 59703-84-3) Market By Type (Piperacillin, Piperacillin and Tazobactam), By Application (Piperacillin Sodium Injection, Piperacillin Sodium Compound Injection), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Beta-lactam and Beta-lactamase Inhibitors Market By Type (Penicillin, Cephalosporin, Carbapenem, Monobactam, Combination), By Application (Oral, Intravenous), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Notoginseng Root Extract Market By Type (Powder Extract, Liquid Extract), By Application (Pharmaceuticals, Cosmetics and Personal Care, Health Supplement Products), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Equine Supplement Products Market By Type (Proteins/Amino Acids, Vitamins, Enzymes, Electrolytes/Minerals), By Application (Veterinary Hospital Pharmacies, Retail Pharmacies), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Medicated Shampoo Market By Type (To Dandruff, Treatment of Psoriasis, Destroy Type, Head-to-head Type, Treat Allergic Reactions), By Application (Hypermarkets/Supermarkets, Convenience Stores, Online), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Cough Suppressant Drugs Market By Type (Dry Cough, Wet Cough), By Application (Hospital, Retail Pharmacy, Online Pharmacy), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Bacteriostatic Antibiotics Market By Type (Tetracycline, Doxycycline, Chloramphenicol, Erythromycin, Fusidic acid, Sulfonamides, Trimethoprim, Macrolides, Lincosamides), By Application (Hospitals, Clinics), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Hemodialysis Vascular Grafts Market By Type (Polyester, Polytetrafluoroethylene, Polyurethane, Biological Materials), By Application (Hospitals, Clinics), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Asthma and COPD Drug Market By Type (Bronchodilators, Anti-inflammatory Drugs, Monoclonal Antibodies, Combination Drugs), By Application (Asthma, COPD), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Famciclovir API Market By Type (Insourced, Outsourced), By Application (Tablet Product, Capsule Product), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Pharmaceuticals for Women\'s Health Market By Type (Granules, Pills, Powder, Tincture, Tablets, Capsule), By Application (Postmenopausal Osteoporosis, Endometriosis, Polycystic Ovarian Syndrome, Pregnancy Disorders), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Montelukast Intermediate Market By Type (GMP, Non-GMP), By Application (Asthma, Allergic Rhinitis, Bronchospasm, Urticaria), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Thyroid Disorder Market By Type (Hypothyroidism, Hyperthyroidism), By Application (Hospitals, Clinics), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
Global Postoperative Pain Therapeutics Market By Type (Oral, Intramuscular, Intravenous), By Application (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Country, and Manufacture - Industry Segment, Competition Scenario and Forecast by 2029
sales@globalresearchview.com
UK +44020 8638 7098
Secure payments with
